Development of Positive Psychotherapy for Smoking Cessation

Completed · Phase 2

Conditions studied: Smoking

In brief

The primary objective of this study is to test a manualized adaptation of positive psychotherapy (PPT) for smoking cessation (PPT-S). The investigators will conduct a preliminary randomized clinical trial (N = 80) to examine the feasibility, acceptability, and efficacy of PPT-S over 26 weeks of follow up in comparison to a standard smoking cessation treatment. Both treatments will be delivered in individual 6 sessions over 6 weeks, and will include provision of transdermal nicotine patch. The effect size estimates from this Stage 1b research will provide the foundation for a future application to conduct a large-scale, Stage II, randomized clinical trial.

Key facts

Study ID

NCT01451814

Run by

Brown University

People needed

66

Starts

2011-10-01

Expected to finish

2014-02-01

Last updated by the study team

2015-03-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• smoke at least 5 cigarettes per day for longer than one year with no other ongoing tobacco product use
• willing to use the transdermal nicotine patch
• report at least a 5 on a 0 to 10 scale rating the importance of quitting smoking.

You may not qualify if…

• are currently experiencing psychotic symptoms, affective disorder (major depression, dysthymia, or mania) or substance use disorder (other than nicotine dependence)
• taking prescribed psychotropic medication or receiving other forms of psychotherapy
• concomitantly using other pharmacotherapies for smoking cessation
• have any contraindications for use of the transdermal nicotine patch.

Where it is running

• Center for Alcohol and Addiction Studies, Brown University — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.